SCOOP: Tylenol Maker Privately Admitted Evidence Was Getting ‘Heavy’ For Autism Risk In 2018

The pharmaceutical company behind Tylenol privately acknowledged the likelihood of an association between its drug in pregnancy and neurodevelopmental disorders like autism in children seven years ago, company documents obtained by the Daily Caller News Foundation show.“The weight of the evidence is starting to feel heavy to me,” said Rachel Weinstein, U.S. director of epidemiology for Janssen, the pharmaceutical arm of Johnson & Johnson, in 2018. Johnson & Johnson marketed Tylenol at the time but in 2023 spun off its consumer products division into a separate company called Kenvue.Legacy media headlines and vocal public health experts have dismissed the conclusion...